Clinical Trial: Efficacy of 0.2 % Digluconate Chlorhexidine Mouthwash for Preventing Alveolar Osteitis After Third Molar Extraction

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Efficacy of DC071 Mouthwash (0.2% Chlorhexidine Digluconate) in Peri-surgical Care for Preventing Alveolar Osteitis After Third Molar Extraction

Brief Summary: The purpose of this study is to demonstrate the efficacy of 0.2 % digluconate chlorhexidine mouthwash in the prevention of alveolar osteitis following third molar extraction and to evaluate the safety and local tolerability.

Detailed Summary:
Sponsor: Pierre Fabre Medicament

Current Primary Outcome: Occurrence of an alveolar osteitis [ Time Frame: Within 7 days ]

The primary Outcome measure will be evaluated based on the absence/presence of an alveolar osteitis within 7 days after the extraction of the third molar.


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Pierre Fabre Medicament

Dates:
Date Received: March 3, 2015
Date Started: March 2015
Date Completion:
Last Updated: March 8, 2016
Last Verified: March 2016